Varicella Zoster Meningitis Treatment
For varicella-zoster virus (VZV) meningitis, treat with intravenous acyclovir 10 mg/kg three times daily for up to 14 days, with consideration of 15 mg/kg three times daily if renal function is normal, as VZV is less sensitive to acyclovir than HSV 1.
Core Treatment Algorithm
Antiviral Therapy
- Start IV acyclovir immediately when VZV meningitis is suspected or confirmed
- Standard dosing: 10 mg/kg IV every 8 hours
- Higher dosing option: 15 mg/kg IV every 8 hours if renal function is normal (VZV requires higher concentrations than HSV)
- Duration: Up to 14 days, especially if started within a few days of symptom onset
- Adjust dose for impaired renal function and monitor renal function frequently 1
Critical timing consideration: Delayed initiation of IV acyclovir is independently associated with residual symptoms—each additional day of delay increases odds of residual symptoms by 30.3% 2. This makes prompt treatment initiation essential for optimal outcomes.
Corticosteroid Consideration
- Short course of corticosteroids (e.g., prednisolone 60-80 mg daily for 3-5 days) is often given with or without acyclovir, due to the inflammatory nature of VZV CNS disease 1
- Stronger indication for steroids if there is a vasculitic component or stroke-like presentation 1, 3
- The evidence supporting corticosteroids is limited but reflects the immune-mediated pathology of VZV meningitis
Special Populations
Immunocompromised Patients
Pediatric Dosing
Important Clinical Distinctions
VZV Cerebellitis vs. Meningitis/Encephalitis
No specific antiviral treatment is needed for VZV cerebellitis 1, 3. This condition is self-limiting (resolves in 1-3 weeks) and represents immune-mediated demyelination rather than direct viral cytopathology. This is a critical distinction—do not treat cerebellitis with antivirals.
Age-Related Presentation Differences
Older patients (≥50 years) often present atypically with:
- Lower rates of headache (75% vs. 97%)
- Less neck stiffness (25% vs. 63%)
- Lower CSF pleocytosis (56/μL vs. 142/μL) 2
Clinical pearl: Maintain high suspicion for VZV meningitis in older adults even without classic meningeal signs.
Common Pitfalls and Caveats
Oral Antivirals Are Insufficient
Prior oral antiviral therapy does not reduce the need for IV acyclovir and is not associated with improved outcomes 2. When VZV meningitis is suspected, proceed directly to IV therapy.
Rash May Be Absent
VZV meningitis can occur in immunocompetent adults without characteristic dermatomal rash 4, 5. Do not exclude the diagnosis based on absence of skin findings—CSF PCR is diagnostic.
Acute Kidney Injury Risk
AKI occurs in 37-52% of patients receiving IV acyclovir for VZV CNS infections 6. Monitor renal function closely throughout treatment, ensure adequate hydration, and infuse acyclovir over 1-2 hours to minimize crystalluria risk.
Treatment Duration Controversy
While guidelines recommend up to 14 days of IV acyclovir, recent evidence suggests that some low-risk patients with isolated VZV meningitis (younger, immunocompetent, no encephalitis features) may have favorable outcomes with shorter courses or even oral therapy alone 7, 6. However, given the strong association between treatment delay and poor outcomes, the conservative approach remains IV acyclovir for the full recommended duration until better evidence emerges from controlled trials.
When to Escalate Care
Transfer to a neurological specialist unit should occur within 24 hours if:
- Diagnosis is not rapidly established
- Patient fails to improve with therapy
- Falling level of consciousness requiring ICU support 1, 3
Monitoring and Follow-up
- Renal function: Check frequently during IV acyclovir therapy
- Clinical response: Expect improvement within days if treatment is started early
- CSF PCR: Remains positive for 7-10 days even after starting acyclovir, so delayed lumbar puncture can still confirm diagnosis 3
- Residual symptoms: Pre-existing functional impairment (higher baseline mRS) predicts worse outcomes 2